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CPS Position Statement

Dietary exposures and allergy prevention in
high-risk infants
A joint statement with the Canadian Society of Allergy and Clinical Immunology
Edmond S Chan, Carl Cummings; Canadian Paediatric Society, Community Paediatrics
Committee and Allergy Section

Allergic conditions in children are a prevalent health concern in
Canada. The burden of disease and the societal costs of proper diagnosis and management are considerable, making the primary prevention
of allergic conditions a desirable health care objective. This position
statement reviews current evidence on dietary exposures and allergy
prevention in infants at high risk for developing allergic conditions. It
revisits previous dietary recommendations for pregnancy, breastfeeding
and formula feeding, and provides an approach for introducing solid
foods to high-risk infants. While there is no evidence that delaying the
introduction of any specific food beyond six months of age helps to
prevent allergy, the protective effect of early introduction of potentially allergenic foods (at four to six months of age) remains under
investigation. Recent research appears to suggest that regularly ingesting a new, potentially allergenic food may be as important as when
that food is first introduced.
Key Words: Allergy prevention; Atopic dermatitis; Breastfeeding; Food
allergy; Formula feeding; Solid food introduction

T

he prevalence of food allergy in Canada, based on selfreported data, is estimated to be approximately 7%, a number sufficient to make primary prevention a desirable health care
goal.(1) Some recent evidence, notably from Australia, suggests
that the prevalence of food allergy in infants is increasing, with
>10% of one-year-olds having an immunoglobulin (Ig)-Emediated food allergy proven by oral challenges.(2) For years,
published guidelines in the United States, Europe and Australia
have examined the relationship between allergy prevention in
high-risk infants and dietary exposures during pregnancy, lactation and early infancy. The American Academy of Pediatrics
changed its advice for allergy prevention in 2008,(3) realigning
their recommendations to be consistent with recent European
and Australian positions.(4-6) The present statement encapsulates the most important changes to these guidelines for Canadian
health care providers, who may not be fully aware of them, and
complements current beliefs regarding allergy prevention in the
United States, Europe and Australia.
The primary objective of this statement is to inform health care
practitioners that best evidence now suggests there is no benefit to
delaying the introduction of any specific solid food, including
highly allergenic proteins, beyond six months of age to prevent
food allergy from developing. It advises against restricting maternal diet during pregnancy and lactation, affirms the immunological
role of breastfeeding, and offers some guidance on the choice of
formula for mothers who cannot or choose not to breastfeed. The
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L’exposition alimentaire et la prévention des
allergies chez les nourrissons à haut risque
Au Canada, les troubles allergiques sont un problème de santé
prévalent chez les enfants. Le fardeau de la maladie et les coûts
sociétaux d’un diagnostic et d’une prise en charge convenables sont
considérables. C’est pourquoi la prévention primaire constitue un
objectif souhaitable en matière de soins. Dans le présent document de
principes, les auteurs analysent les données probantes à jour sur
l’exposition alimentaire et la prévention des allergies chez les
nourrissons à haut risque de troubles allergiques. Ils revoient les
recommandations antérieures en matière d’alimentation pendant la
grossesse, l’allaitement et l’alimentation au moyen de préparations
lactées et proposent une approche pour introduire les aliments solides
chez les nourrissons à haut risque. Aucune donnée probante n’indique
que le fait de reporter l’introduction de certains aliments après six mois
contribue à prévenir les allergies, mais l’effet protecteur de l’introduction
précoce d’aliments au potentiel allergène (entre quatre et six mois) fait
l’objet d’études. Les recherches récentes laissent supposer que la
consommation régulière d’un nouvel aliment au potentiel allergène
peut être tout aussi importante que le moment de son introduction.

recommendations in this statement do not apply to infants with an
established food allergy.
DEFINING RISK
An infant at high risk for developing allergy usually has a firstdegree relative (at least one parent or sibling) with an allergic
condition such as atopic dermatitis, a food allergy, asthma or allergic rhinitis.(7) This defining relationship corresponds with other
published guidelines. While recommendations in the present
statement are intended for high-risk infants, some of the studies
cited below included infants from the general population who
were not considered to be at high risk for developing allergy.
MATERNAL DIET AND BREASTFEEDING DURATION
Evidence to support maternal dietary restrictions during pregnancy is contradictory and insufficient to change best practice.
(3-6) A recent Cochrane review found little evidence that
avoiding milk, egg or other potential allergens during pregnancy
reduced the risk of atopic eczema or asthma in infants.(8) Recent
reports investigating the effect of ingesting peanut during pregnancy were also inconclusive, with authors providing only cautious interpretation of study results because randomized,
prospective data were lacking.(9) Similarly, restricting the
maternal diet while breastfeeding has not been proven to prevent
allergic conditions in infants, with the possible exception of
atopic eczema. Higher-quality studies are needed.(8) However,
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while the evidence that restricting maternal diet during pregnancy and lactation helps to prevent allergy is weak, the risks of
maternal undernutrition and potential harm to the infant from
avoiding these foods may be significant.
Health Canada, the Canadian Paediatric Society (CPS), the
Dietitians of Canada and the Breastfeeding Committee of
Canada have reiterated the manifest health benefits of exclusive
breastfeeding for the first six months of life – which include
immunological protection – in a recent position statement.(10)
However, the role of breastfeeding in preventing allergy remains
unclear because previous studies of the relationship have been
insufficiently rigorous or lacked ideal methodological design. To
date, studies have been largely observational, nonuniform in
terms of breastfeeding duration, and too variable in the diagnostic criteria for allergic conditions.(11) There is some evidence
that in infants at high risk of allergy, exclusive breastfeeding for
at least the first four months of life is associated with decreased
prevalence of atopic dermatitis and cow’s milk allergy during
childhood.(12) However, a more recent study failed to show a
protective effect of breastfeeding on atopic dermatitis.(13) There
may be evidence of decreased wheezing before four years of age
with at least three months of breastfeeding,(14) but there is
either no effect or possibly even an increased risk of asthma after
six years of age associated with a similar duration of breastfeeding.(15)
Some allergy prevention guidelines favour four to six months of
exclusive breastfeeding, compared with the WHO’s recommendation of six months, because of potential benefit from tolerance to
solid foods during a theoretical ‘window of opportunity’ between
four and six months of age.(3,4,6) Also, there is a lack of evidence
supporting the benefit of avoiding solid foods beyond four months
of age to prevent allergy. Some specialists have proposed a compromise: starting to introduce solid foods at four months of age
while continuing to breastfeed until an infant is at least six months
of age.(16) Working with this compromise may depend on weighing an infant’s unique atopic risk factors against the many benefits
of exclusive breastfeeding for six months. A recent randomized
study has suggested that introducing solid foods at four months of
age while maintaining breastfeeding for at least six months has no
impact on growth and improves iron status.(17) Furthermore, one
recent prospective cohort study showed that introducing solid
foods before six months of age was associated with decreased
asthma, allergic rhinitis and atopic sensitization at five years of
age.(18) The same study reported that the total duration of breastfeeding was more important for preventing these allergic conditions than exclusive breastfeeding. More research needs to be
conducted to confirm these findings. An article published in
2013 by the American Academy of Allergy, Asthma and
Immunology has similarly focused on breastfeeding for four to six
months of age and the introduction of complementary foods during the same interval in preventing allergy.(19)
CHOICE OF FORMULA
All current recommendations favour breastfeeding over formula
feeding. There have been no long-term studies comparing exclusive breastfeeding with formula feeding in allergy prevention
because it would be unethical to randomize infants to breast- or
formula feeding. Therefore, only different infant formulas can be
compared in relation to allergy development.
There is limited evidence to suggest that childhood allergy can
be prevented in high-risk infants by using certain hydrolyzed cow’s
milk formulas in the first four to six months of life, compared with
intact cow’s milk formula.(20) Of the hydrolyzed formulas, extensively hydrolyzed casein formula is more likely to be effective in
546

preventing atopic dermatitis in high-risk infants than partially
hydrolyzed whey formula.(21-23) Some formula studies were
industry sponsored.
One recent prospective study suggested that introducing cow’s
milk formula to supplement breastfeeding during the first 14 days
of life, followed by regular, daily supplementation of breastfeeding
with the same formula, may help to prevent cow’s milk allergy by
developing tolerance mechanisms.(24) More research is needed to
confirm this observation. Studies have suggested an association
between lower incidence of atopic dermatitis and the use of hydrolyzed formulas compared with intact cow’s milk formulas, so it is
unclear how the potential benefit from early cow’s milk formula
supplementation may affect best practice in future. Introducing
cow’s milk formula this early would, at the very least, contradict
current recommendations from Health Canada, the CPS and the
WHO to breastfeed exclusively for the first six months of life for
overall health benefit.
No studies have examined the role of amino-acid formulas in
allergy prevention, and there is consensus in the literature that soy
formula does not have a role.(3) It is unclear whether formula feeding in early infancy has any role in preventing allergic conditions
other than atopic dermatitis, and also unclear whether formula
feeding has any preventive effect long term. No clear recommendations for choice of formula can be made, given the lack of conclusive evidence related to allergy prevention.
INTRODUCING SOLID FOODS
In 2000, the American Academy of Pediatrics recommended
delaying the introduction of potential ‘trigger’ foods (eg, cow’s
milk protein until one year of age, egg until two years of age, and
peanut or seafood until three years of age) for infants at high risk
of developing allergy.(25) This advice was based on expert opinion
because there were no convincing data to support this position at
the time.
Since 2000, however, accumulating observational evidence has
suggested that delaying the introduction of certain foods does not
prevent food allergy; rather, it may actually promote allergy
development.(26) There is increasing speculation that a later
introduction of peanut has increased the prevalence of peanut
allergy. One study in the United Kingdom showed that the prevalence of peanut allergy tripled during the period when public
health practitioners were advising parents to delay peanut introduction.(27) Another observational study reported the prevalence
of peanut allergy among Jewish children living in Israel at onetenth that of Jewish children living in the United Kingdom. Most
infants in Israel were ingesting peanut protein during the first year
of life, while infants born in the United Kingdom consumed
almost none.(28) An American study suggested that delaying the
introduction of wheat and cereal grains beyond six months of age
increases the subsequent risk of wheat allergy.(29)
A ‘dual-allergen-exposure hypothesis’ has been proposed to
explain why delaying the introduction of specific solid foods has
contributed to the rise in food allergy incidence.(30) The hypothesis suggests that infants with eczema as an initial risk factor have
increased environmental exposure to food topically, via ‘broken’
skin, a sensitizing route of exposure. Delaying introduction to the
same food does not permit the infant to derive potential benefits
from regular oral and gastrointestinal exposure, or to develop tolerance via regulatory T cell pathways. In support of sensitization via
the skin, a recent study has shown that mutations in filaggrin, a
gene key to maintenance of the skin barrier, are a risk factor for
IgE-mediated peanut allergy.(31) Another study suggested that
infants with a high environmental exposure to peanut but no oral
exposure are at increased risk of developing peanut allergy.(32)
Paediatr Child Health Vol 18 No 10 December 2013
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The American Academy of Pediatrics issued a new guideline in
2008 that concluded there was no convincing evidence that
delaying the introduction of solid foods, including peanut, egg and
fish, beyond four to six months of age has a significant protective
effect on allergy prevention.(3) Their conclusion was consistent
with recommendations from the European Academy of Allergology
and Clinical Immunology, the European Society for Pediatric
Gastroenterology, Hepatology and Nutrition, and the Australasian
Society of Clinical Immunology and Allergy.(4-6)
Whether an earlier introduction of solid foods (eg, at or
before four to six months of age) has a truly preventive effect also
remains to be established. However, emerging data suggests that
it is possible. A Swedish study published in 2006 involving a
cohort of 4089 infants concluded that regular fish consumption
in the first year of life was associated with lower risk of allergic
disease (OR 0.76 [95% CI 0.61 to 0.94]) and reduced allergic
sensitization for the first four years of life.(33) A recent crosssectional study from Australia demonstrated that delaying egg
introduction for the first year of life resulted in a 3.4-fold higher
risk of developing egg allergy compared with egg introduction at
any time between four and six months of age.(34) The Learning
Early About Peanut (LEAP) allergy study has been underway for
several years in the United Kingdom. This is a prospective trial
randomly assigning high-risk infants to either an early introduction of peanut protein (at four to 10 months of age) or delayed
introduction (until three years of age), with ongoing exposures of
three times per week once introduced.(35) When the study
cohort reaches five years of age, there will be evaluation of the
presence or absence of peanut allergy using oral challenges. The
same investigators have created the Enquiring About Tolerance
(EAT) study to determine whether even earlier introduction of
specific foods decreases the risk of food allergy. Their prospective
trial randomly assigned unselected infants with no increased risk
of allergy to regular consumption (ie, several times per week) of
allergenic foods (eg, cow’s milk, egg, peanut, fish, sesame, wheat)
starting at either three or six months of age.(36) The stipulation
for regular ingestion is based on studies examining mechanisms
of oral tolerance. It appears that early introduction alone is
insufficient to achieve a preventive effect; regular exposure is
equally important.(30) Results from the LEAP and EAT studies
are expected within the next few years.
Until the results of LEAP, EAT and other clinical trials become
available, uncertainty remains. Deciding whether to introduce
potentially allergenic solid foods to high-risk infants early should
be individualized and based on parental comfort level. The choice
of using an older ‘delayed introduction’ approach, with no proven
benefit and, possibly, an increased risk of food allergy, versus an
unproven ‘early introduction’ approach, whose potential benefits
are based on preliminary data, is difficult for clinicians to make.
Other factors, such as having an older sibling with peanut allergy
or parental reluctance to introduce peanut until testing by a certified allergist has occurred, may complicate decision making. It is
worth noting that routine screening for allergy to a food using a
skin test or specific IgE blood test without a history of the child
ever ingesting the food in question is generally discouraged. The
high risk of false-positive results can be confusing.(19) For the
family reluctant to introduce a food because of family history or for
other reasons, referral to a certified allergist is a better course. A
specialist can decide whether an oral food challenge is warranted.
Regardless of timing, once a new food is introduced by parents, it
appears prudent to recommend regular exposures (eg, several times
per week and with a soft mashed consistency to avoid risk of choking) to maintain oral tolerance.
Paediatr Child Health Vol 18 No 10 December 2013

CONCLUSIONS
There has been a recent shift in evidence-based practice to prevent food allergy in high-risk infants. Delaying the introduction of
certain ‘trigger’ foods for periods previously recommended has
been shown to have no protective effect on allergic sensitization
and disease development. While the benefits of introducing these
foods to infants earlier, at four to six months of age, are yet to be
determined, the immunological mechanisms of sensitization and
tolerance tend to support the latter approach. Regardless of the
optimal timing for introduction, current understanding of immunological tolerance also appears to suggest that regular, frequent oral
consumption may be just as important as when a food is first
introduced.
RECOMMENDATIONS
Based on current evidence, and always conceding that much more
research needs to be performed, the CPS and the Canadian
Society of Allergy and Clinical Immunology recommend the following approach to prevent allergy in infants who have a first-degree relative with an allergic condition, and are, therefore,
considered to be high risk. The levels of evidence reported in the
recommendations have been described using the evaluation of
evidence criteria outlined by the Canadian Task Force on
Preventive Health Care.(37)
• Do not restrict maternal diet during pregnancy or lactation.
There is no evidence that avoiding milk, egg, peanut or other
potential allergens during pregnancy helps to prevent allergy,
while the risks of maternal undernutrition and potential harm
to the infant may be significant. (Evidence II-2B)
• Breastfeed exclusively for the first six months of life. Whether
breastfeeding prevents allergy as well as providing optimal
infant nutrition and other manifest benefits is not known.
The total duration of breastfeeding (at least six months) may
be more protective than exclusive breastfeeding for six
months. (Evidence II-2B)
• Choose a hydrolyzed cow’s milk-based formula, if necessary.
For mothers who cannot or choose not to breastfeed, there is
limited evidence that hydrolyzed cow’s milk formula has a
preventive effect against atopic dermatitis compared with
intact cow’s milk formula. Extensively hydrolyzed casein
formula is likely to be more effective than partially
hydrolyzed whey formula in preventing atopic dermatitis.
Amino acid-based formula has not been studied for allergy
prevention, and there is no role for soy formula in allergy
prevention. It is unclear whether any infant formula has a
protective effect for allergic conditions other than atopic
dermatitis. (Evidence IB)
• Do not delay the introduction of any specific solid food
beyond six months of age. Later introduction of peanut, fish
or egg does not prevent, and may even increase, the risk of
developing food allergy. (Evidence II-2B)
• More research is needed on the early introduction of specific
foods to prevent allergy. Inducing tolerance by introducing
solid foods at four to six months of age is currently under
investigation and cannot be recommended at this time. The
benefits of this approach need to be confirmed in a rigorous
prospective trial. (Evidence II-2B)
• Current research on immunological responses appears to
suggest that the regular ingestion of newly introduced foods
(eg, several times per week and with a soft mashed
consistency to prevent choking) is important to maintain
547
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tolerance. However, routine skin or specific IgE blood testing
before a first ingestion is discouraged due to the high risk of
potentially confusing false-positive results. (Evidence II-2B)

16.

RESOURCE FOR FAMILIES
• HealthLink BC, 2013. Reducing risk of food allergy in your
baby: A resource for parents of babies at increased risk of food
allergy. Endorsed by the Canadian Society of Allergy and
Clinical Immunology: www.healthlinkbc.ca/healthyeating/pdf/
reducing-risk-of-food-allergy-in-your-baby.pdf
Acknowledgements: This statement was reviewed by the
Nutrition and Gastroenterology Committee of the Canadian Paediatric
Society. It has been reviewed and endorsed by Dietitians of Canada.
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